Manuel N. is a highly experienced professional in the field of drug discovery and development, currently serving as a Drug Discovery and Development Advisor at QurAlis, Artugen Therapeutics, ClearB Therapeutics, and Stealth BioTherapeutics since January 2017, July 2016, July 2016, and January 2014, respectively. As a Co-Founder, Manuel N. has played significant roles at EnClear Therapies and Estabrook Pharmaceuticals since June 2018 and 2008, respectively, and at eXIthera Pharmaceuticals since 2012. Additionally, Manuel N. is the President of Hub-Bio Strategic Advising, a position held since 2003, while also contributing to the field as an Executive-in-Residence at Oxford Bioscience Partners from 2003 to 2016 and as a Founder and member of the Board of Directors for Altus Pharmaceuticals from 1993 to 2010. Manuel N. holds a Doctor of Philosophy in Biophysics and a Master of Science in Biophysics from the University of Chicago, as well as a Bachelor of Arts in Physics from New York University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices